Galectin Therapeutics Inc (FRA:PHPN)
€ 2.38 0.04 (1.71%) Market Cap: 151.00 Mil Enterprise Value: 213.71 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Galectin Therapeutics Inc Annual Shareholders Meeting Transcript

Dec 01, 2022 / 04:00PM GMT
Release Date Price: €1.2
Operator

Good day, and welcome to the Galectin Therapeutics Annual Meeting of Stockholders. I would now like to turn the conference over to Kevin Freeman, Vice Chairman of the Board. Please go ahead, sir.

Kevin Freeman
Galectin Therapeutics Inc. - Vice Chairman of the Board

Good morning, ladies and gentlemen, welcome. My name is Kevin Freeman and I am the Vice Chairman of the Board of Galectin Therapeutics Inc. I will act as Chair of the meeting, and Mr. Jack Callicutt, our Chief Financial Officer and Corporate Secretary, will act as secretary.

Due to the potential ongoing issues with regard to the COVID-19 pandemic, we are holding this year's annual meeting as a virtual meeting. Stockholders who require technical assistance during the meeting can call Broadridge's technical support line at the number listed on our virtual meeting website. Thank you.

I hereby call the 2022 Annual Meeting for Galectin Therapeutics Inc. to order. At this time, I would like to introduce the current members of the Board of Directors, Dr. Gilbert Amelio, Director, Member

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot